TFCT NIB (Tofacitinib (5mg))

Tfct-Nib Tablet is indicated for the management of moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. By targeting inflammation, it effectively alleviates discomfort, tenderness, and swelling in the joints, while also working to hinder the degeneration of bones and joints. This medication may be administered alone or in conjunction with another treatment, tailored to your specific medical needs. It is advised to take these tablets consistently, at the same time each day, regardless of food intake. Your healthcare provider will determine the appropriate dosage based on your condition and any other medications you may be taking. It is crucial to adhere to your doctor’s instructions regarding this treatment and to avoid discontinuation without consulting them, as doing so may exacerbate your condition. Routine blood tests may be necessary before initiating therapy, and starting this medication in the presence of an active infection is not recommended. If you have a history of tuberculosis, shingles, liver or kidney ailments, hepatitis B or C, or venous thromboembolism, inform your physician prior to treatment. Tfct-Nib Tablet may increase susceptibility to infections or exacerbate existing ones, thus minimizing exposure to contagious individuals (e.g., those with chickenpox or the flu) is advisable. This medication is contraindicated in individuals under 18 years of age, and its use during pregnancy or breastfeeding should only occur if the healthcare provider has deemed the potential advantages to outweigh the risks. Regular medical evaluations may be necessary throughout the course of treatment.